Q1 FY27 results approved, AGM on Sept 28, new Independent Director

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

GKSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+11.4%Reaction day

₹136.70

prior close

₹135.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+11.3% vs market

Hospital peers, median of 25sector-0.7%+12.1% vs sector

On the reaction day the stock moved 11.3 pts more than Nifty Microcap 250 and 12.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.9

10m

+6.3

15m

+6.0

30m

+9.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+11.4+0.1+11.3-0.7+12.1

Next day

+11.8+0.5+11.3-0.5+12.3

+14.8-0.1+14.9-1.1+16.0

+14.3+0.4+13.9-0.7+15.0

+11.9+0.7+11.2-1.1+13.0

+11.4+0.9+10.5-1.2+12.6

+11.6+1.1+10.5-1.3+12.9

15d

+30.1+1.6+28.5-1.4+31.5

+30.9-0.7+31.6-1.3+32.2

+37.5-3.2+40.8-14.6+52.1

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved un-audited Q1 FY27 results. Standalone revenue rose 23.9% YoY to Rs. 1,144.99 lacs. PAT jumped 48.9% to Rs. 203.71 lacs (EPS Rs. 0.26). Auditor issued unmodified limited review report. Board's Report for FY26 approved. 7th AGM on Sept 28, 2026. Mr. Paresh Dhoti appointed as Additional Non-Executive Independent Director.

Likely market impact

Standalone Q1 revenue up 23.9%, PAT up 48.9% YoY. AGM and new director are routine items.